Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia. 2007

Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
Department of Anaesthesiology, Intensive Therapy and Pain, University of Medical Sciences, PoznaƄ, Poland.

BACKGROUND The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). METHODS Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia. RESULTS The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p < 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p < 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p < 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p < 0.01) in the remifentanil group. CONCLUSIONS As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D010880 Piperidines A family of hexahydropyridines.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077208 Remifentanil A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care. 3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester,GI 87084B,GI-87084B,GI87084B,Remifentanil Hydrochloride,Remifentanil Monohydrochloride,Ultiva
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000762 Anesthesia Recovery Period The period of emergence from general anesthesia, where different elements of consciousness return at different rates. Recovery Period, Anesthesia,Anesthesia Recovery Periods,Period, Anesthesia Recovery,Periods, Anesthesia Recovery,Recovery Periods, Anesthesia
D000771 Anesthesia, Intravenous Process of administering an anesthetic through injection directly into the bloodstream. Anesthesias, Intravenous,Intravenous Anesthesia,Intravenous Anesthesias

Related Publications

Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
March 1998, Anaesthesia,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
July 2002, European journal of anaesthesiology,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
February 2006, Anaesthesia and intensive care,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
September 2005, European journal of anaesthesiology,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
January 2003, European journal of anaesthesiology,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
April 2008, Journal of clinical monitoring and computing,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
March 1988, Anaesthesia,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
April 1998, Anaesthesia,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
October 2003, Paediatric anaesthesia,
Zbigniew Zaba, and Agnieszka Bienert, and Leon Drobnik, and Stanislaw Dyderski, and Krzysztof Kusza
April 1998, Anaesthesia and intensive care,
Copied contents to your clipboard!